Medication Management During Hospital-to-Home Transitions of Older Adults with Alzheimer's Disease and Related Dementias (ADRD)
患有阿尔茨海默病和相关痴呆症 (ADRD) 的老年人从医院到家庭过渡期间的药物管理
基本信息
- 批准号:9914197
- 负责人:
- 金额:$ 16.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAlzheimer&aposs disease related dementiaAreaBehavioralBehavioral ModelCaregiversCaringDiscipline of NursingDiseaseEffectivenessElderlyElementsEngineeringEvaluationFaceFoundationsFutureGeneral PopulationGoalsHealthHealth PersonnelHealth ServicesHealth systemHealthcareHome environmentHospitalsHumanInterventionInterviewMedication ErrorsMedication ManagementMovementNursing ServicesParticipantPatient CarePatientsPersonsPharmaceutical PreparationsPhysical environmentPopulationPrincipal InvestigatorProcessProviderRegimenRehabilitation therapyResearchResearch PersonnelRiskRoleSafetyShapesStructureSystemTestingTimeUnited States National Institutes of HealthVariantVisitVisiting NurseWorkcare recipientsdesigndiariesergonomicsexpectationexperiencehealth care settingshigh riskimprovedinformal caregivermultidisciplinarynovelpatient safetytherapy developmenttool
项目摘要
Care transitions are the movement of a person from one healthcare setting to another. The hospital-to-home
transition is a high-risk period, especially for medication errors and adverse events and for persons with
Alzheimer's disease and related dementias (ADRD). There is relatively little research to guide care transition
improvement efforts for the ADRD population. An area of particular risk for older adults with ADRD during the
hospital-to-home transition is role ambiguity regarding medication management (MM). Role ambiguity in MM
occurs when the roles of older adults with ADRD, informal caregivers, and healthcare providers remain without
a clear definition of who is responsible for completion of MM-related tasks, such as medication reconciliation.
The goal of the current proposal is to (1) identify issues related to role ambiguity regarding medication
management that threaten the safety of older adults with ADRD during hospital-to-home transitions, and (2)
engage stakeholders to develop a set of strategies specific to ADRD to decrease role ambiguity and support
MM during this high-risk transition.
Specific Aim 1: Identify critical tasks regarding medication management and categorize factors shaping
expectations for task distribution during hospital-to-home transitions of older adults with ADRD. We will
develop process-flow diagrams of critical MM tasks and categorize factors shaping older adult and informal
caregiver expectations for MM task distribution through (1) direct observations and interviews during initial home
health visits of recently hospitalized older adults with ADRD and their informal caregivers; (2) photographs of
objects used to support MM in the home; and (3) solicited participant diaries followed by post-diary semi-
structured interviews with informal caregivers.
Specific Aim 2: Identify and prioritize stakeholder strategies to manage expectations and distribute tasks
to decrease role ambiguity and support successful medication management during hospital-to-home
transitions. Guided by a participatory ergonomics approach from the field of human factors engineering, we will
form an intervention refinement team (IRT) comprised of older adults with ADRD, informal caregivers, and
healthcare providers involved in hospital-to-home transitions. The IRT will meet to use findings from the hospital-
to-home process-flow diagram (Aim 1) to develop strategies and rate each strategy according to (1) importance
to reducing role ambiguity, (2) likelihood of effectiveness in supporting MM, and (3) level of actionability.
The long-term goal of our research is to develop, evaluate, and disseminate best practices to deliver optimal
health care to older adults with ADRD in all stages of disease as they transition across healthcare settings.
Completion of these aims will result in a stakeholder-informed set of strategies to support MM. Study findings
will build a foundation for future work to develop and test a behavioral or technological solution to address
unmet needs and safety risks during the hospital-to-home transition for older adults with ADRD.
护理过渡是指一个人从一个医疗保健机构转移到另一个医疗保健机构。的hospital-to-home
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alicia Ines Arbaje其他文献
Alicia Ines Arbaje的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alicia Ines Arbaje', 18)}}的其他基金
PA-20-070: Evaluating home healthcare agency and home healthcare professional responsiveness to safety threats during older adults' care transitions in the era of COVID-19
PA-20-070:评估家庭医疗保健机构和家庭医疗保健专业人员对 COVID-19 时代老年人护理过渡期间安全威胁的响应能力
- 批准号:
10172490 - 财政年份:2019
- 资助金额:
$ 16.38万 - 项目类别:
Older adult safety while receiving home health services after hospital discharge
老年人出院后接受家庭保健服务时的安全
- 批准号:
8828082 - 财政年份:2014
- 资助金额:
$ 16.38万 - 项目类别:
Older adult safety while receiving home health services after hospital discharge
老年人出院后接受家庭保健服务时的安全
- 批准号:
8678190 - 财政年份:2014
- 资助金额:
$ 16.38万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 16.38万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 16.38万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 16.38万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 16.38万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 16.38万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 16.38万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 16.38万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 16.38万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 16.38万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 16.38万 - 项目类别: